Abiopharma

🔍 Pauls Dietrich John (Executive)

Company: DiaMedica Therapeutics Inc. (DMAC)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 60,200 shares of Voting Common Shares, no par value per share (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 128,791.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The restricted stock units will vest in four equal installments, each on the first, second, third, and fourth anniversaries of the grant date, provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.
• F2: Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.